EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation

Endry Wahyu Syahputra, Hyunji Lee, Hyukjun Cho iD, Hyun Jin Park iD, Kwang-Su Park iD, Duhyeong Hwang

Pharmaceutics · 09.04.2025 · 17 (4) · 501

DOI: 10.3390/pharmaceutics17040501 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 09.04.2025. Verfasst von Endry Wahyu Syahputra und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea government (MSIT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis targeting chimeras (PROTACs), heterobifunctional molecules that hijack the ubiquitin–proteasome system (UPS) to degrade specific proteins, hold great promise in treating diseases driven by traditionally “undruggable” targets. However, their large molecular weight, high hydrophobicity, and other physicochemical hurdles contribute to their limited bioavailability, suboptimal pharmacokinetics, and attenuated therapeutic efficacy. Consequently, diverse formulation innovations have been investigated to optimize PROTAC delivery. This review examines current challenges and advances in specialized drug delivery approaches designed to bolster PROTAC pharmacological performance. We first outline the fundamental limitations of PROTACs—their low aqueous solubility, poor cell permeability, rapid clearance, and concentration-dependent “hook effect”. We then discuss how various enabling formulations address these issues, including polymeric micelles, emulsions, amorphous solid dispersions, lipid-based nanoparticles, liposomes, and exosomes. Collectively, these delivery technologies substantially improve the therapeutic outcomes of PROTACs in preclinical cancer models. Future applications may extend beyond oncology to address other complex diseases using newly emerging heterobifunctional molecules. By integrating advanced formulation science with innovative degrader design, the field stands poised to unlock the clinical potential of PROTACs for protein degradation therapies.

Schlagwörter

Stichwörter der Autor:innen

PROTACbioavailabilitydrug delivery systemphysicochemical propertysolubilization

Autor:innen und Institutionen

  • College of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea.
  • College of Pharmacy, Kyungsung University, Busan 48434, Republic of Korea.

ORCID-Profile: Hyukjun Cho, Hyun Jin Park, Kwang-Su Park

Förderung

  • Korea government (MSIT)

Zitieren

APA

Syahputra, E. W., Lee, H., Cho, H., Park, H. J., Park, K. S., & Hwang, D. (2025). PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation. Pharmaceutics, 17(4), 501. https://doi.org/10.3390/pharmaceutics17040501

Vancouver

Syahputra EW, Lee H, Cho H, Park HJ, Park KS, Hwang D. PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation. Pharmaceutics. 2025;17(4):501. doi:10.3390/pharmaceutics17040501

BibTeX
@article{Syahputra2025,
  author = {Syahputra, Endry Wahyu and Lee, Hyunji and Cho, Hyukjun and Park, Hyun Jin and Park, Kwang-Su and Hwang, Duhyeong},
  title = {PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {4},
  pages = {501},
  doi = {10.3390/pharmaceutics17040501}
}
Kostenlos starten →